Sara Bech
Research Subjects
Sara Bech has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Joergen Erik Nielsen
Neurogenetics Clinic & Research Lab, Danish Dementia Research Centre, Rigshospitalet, Copenhagen, Denmark
2 shared publications Lena E. Hjermind
2 shared publications- Albert Gjedde
Department of Neuroscience, University of Copenhagen, Panum Institute, Copenhagen, Denmark
1 shared publication - Anne Nørremølle
Section of Neurogenetics, Department of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark
1 shared publication - Annemette Løkkegaard
Department of Neurology, Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen, Denmark
1 shared publication - Emil Karl Gustavsson
UK Dementia Research Institute, University of Cambridge, Cambridge, UK
1 shared publication
Latest Publications
- 4 November 2014
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 21 (1) , 75-78
Parkinson's disease, genetic variability and the Faroe Islands
- 4 November 2014
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 21 (1) , 75-78
Parkinson's disease, genetic variability and the Faroe Islands
- Open Access
- 13 August 2012
- Published by Springer Nature in BMC Neurology
- Vol. 12 (1) , 73
Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: A case report
The autosomal dominant spinocerebellar ataxias (SCAs) confine a group of rare and heterogeneous disorders, which present with progressive ataxia and numerous other features e.g. peripheral neuropathy, macular degeneration and cognitive impairment, and a subset of these disorders is caused by CAG-repeat expansions in their respective genes. The diagnosing of the SCAs is often difficult due to the phenotypic overlap among several of the subtypes and with other neurodegenerative disorders e.g. Huntington’s disease. We report a family in which the proband had rapidly progressing cognitive decline and only subtle cerebellar symptoms from age 42. Sequencing of the TATA-box binding protein gene revealed a modest elongation of the CAG/CAA-repeat of only two repeats above the non-pathogenic threshold of 41, confirming a diagnosis of SCA17. Normally, repeats within this range show reduced penetrance and result in a milder disease course with slower progression and later age of onset. Thus, this case presented with an unusual phenotype. The current case highlights the diagnostic challenge of neurodegenerative disorders and the need for a thorough clinical and paraclinical examination of patients presenting with rapid cognitive decline to make a precise diagnosis on which further genetic counseling and initiation of treatment modalities can be based.
- 13 August 2012
- Published by Springer Nature in BMC Neurology
- Vol. 12 (1) , 73
Open AccessSevere and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: A case report
The autosomal dominant spinocerebellar ataxias (SCAs) confine a group of rare and heterogeneous disorders, which present with progressive ataxia and numerous other features e.g. peripheral neuropathy, macular degeneration and cognitive impairment, and a subset of these disorders is caused by CAG-repeat expansions in their respective genes. The diagnosing of the SCAs is often difficult due to the phenotypic overlap among several of the subtypes and with other neurodegenerative disorders e.g. Huntington’s disease. We report a family in which the proband had rapidly progressing cognitive decline and only subtle cerebellar symptoms from age 42. Sequencing of the TATA-box binding protein gene revealed a modest elongation of the CAG/CAA-repeat of only two repeats above the non-pathogenic threshold of 41, confirming a diagnosis of SCA17. Normally, repeats within this range show reduced penetrance and result in a milder disease course with slower progression and later age of onset. Thus, this case presented with an unusual phenotype. The current case highlights the diagnostic challenge of neurodegenerative disorders and the need for a thorough clinical and paraclinical examination of patients presenting with rapid cognitive decline to make a precise diagnosis on which further genetic counseling and initiation of treatment modalities can be based.
- 1 January 2012
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 18 (1) , 69-72
Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
- 1 January 2012
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 18 (1) , 69-72
Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
- 1 January 2010
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 16 (1) , 12-15
Huntington's disease-like and ataxia syndromes: Identification of a family with a de novo SCA17/TBP mutation
- 1 January 2010
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 16 (1) , 12-15
Huntington's disease-like and ataxia syndromes: Identification of a family with a de novo SCA17/TBP mutation